Biological effects of TrkA and TrkB receptor signaling in neuroblastoma
- PMID: 15921851
- DOI: 10.1016/j.canlet.2005.02.051
Biological effects of TrkA and TrkB receptor signaling in neuroblastoma
Abstract
The Trk family consists of three receptor tyrosine kinases, each of which can be activated by one or more of four neurotrophins-NGF, BDNF, NT3 and NT4. Neurotrophins mediate their multiple effects through a number of distinct intracellular signaling cascades regulating such diverse biological responses as cell survival, proliferation and differentiation in normal and neoplastic neuronal cells. Expression of Trk receptors also plays an important role in the biology and clinical behavior of neuroblastomas. High expression of TrkA is present in neuroblastomas with favorable biological features and highly correlated with patient survival, whereas TrkB is mainly expressed on unfavorable, aggressive neuroblastomas. This short review discusses recent data on the biological roles of TrkA and TrkB signaling in neuroblastoma.
Similar articles
-
Prognostic and biological role of neurotrophin-receptor TrkA and TrkB in neuroblastoma.Klin Padiatr. 2000 Jul-Aug;212(4):200-5. doi: 10.1055/s-2000-9677. Klin Padiatr. 2000. PMID: 10994551
-
Microarray analysis reveals differential gene expression patterns and regulation of single target genes contributing to the opposing phenotype of TrkA- and TrkB-expressing neuroblastomas.Oncogene. 2005 Jan 6;24(1):165-77. doi: 10.1038/sj.onc.1208000. Oncogene. 2005. PMID: 15637590
-
Expression of the TrkA or TrkB receptor tyrosine kinase alters the double-strand break (DSB) repair capacity of SY5Y neuroblastoma cells.DNA Repair (Amst). 2008 Oct 1;7(10):1757-64. doi: 10.1016/j.dnarep.2008.07.004. Epub 2008 Aug 20. DNA Repair (Amst). 2008. PMID: 18678285
-
Trk receptor expression and inhibition in neuroblastomas.Clin Cancer Res. 2009 May 15;15(10):3244-50. doi: 10.1158/1078-0432.CCR-08-1815. Epub 2009 May 5. Clin Cancer Res. 2009. PMID: 19417027 Free PMC article. Review.
-
Trk kinase inhibitors as new treatments for cancer and pain.Expert Opin Ther Pat. 2009 Mar;19(3):305-19. doi: 10.1517/13543770902721261. Expert Opin Ther Pat. 2009. PMID: 19441906 Review.
Cited by
-
Therapeutic efficacy of silibinin on human neuroblastoma cells: Akt and NF-κB expressions may play an important role in silibinin-induced response.Neurochem Res. 2012 Sep;37(9):2053-63. doi: 10.1007/s11064-012-0827-9. Epub 2012 Jun 21. Neurochem Res. 2012. PMID: 22717697
-
c.1810C>T polymorphism of NTRK1 gene is associated with reduced survival in neuroblastoma patients.BMC Cancer. 2009 Dec 13;9:436. doi: 10.1186/1471-2407-9-436. BMC Cancer. 2009. PMID: 20003389 Free PMC article.
-
Pediatric low-grade glioma in the era of molecular diagnostics.Acta Neuropathol Commun. 2020 Mar 12;8(1):30. doi: 10.1186/s40478-020-00902-z. Acta Neuropathol Commun. 2020. PMID: 32164789 Free PMC article. Review.
-
Olive Oil Components as Novel Antioxidants in Neuroblastoma Treatment: Exploring the Therapeutic Potential of Oleuropein and Hydroxytyrosol.Nutrients. 2024 Mar 13;16(6):818. doi: 10.3390/nu16060818. Nutrients. 2024. PMID: 38542729 Free PMC article. Review.
-
Retinoic acid-induced CHD5 upregulation and neuronal differentiation of neuroblastoma.Mol Cancer. 2015 Aug 7;14:150. doi: 10.1186/s12943-015-0425-y. Mol Cancer. 2015. PMID: 26245651 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical